5Axelsen R A,Crawford D H,Endre Z H. Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation[J].Pathology,1995,(03):327-346.
1Storri S, Santoni T, Minunni M, et al. Surface modifications for the development of piezoimmunosensors[J]. Biosens Bioelectron, 1998,13(3-4): 347-357.
2Guder WG, Ivandic M, Hofmann W, et al. Physiopathology of proteinuria and laboratory diagnostic strategy based on single protein analysis[J]. Clin Chem Lab Med, 1998,36(2) :935-939.
3Hiratsuka N, et al. Analysis of urinary albumin, tranferrin,Nacrtyl beta Dglucosaminidase and beta 2 microglobuin in patients with impaired glucose tolerance[J]. J Clin Lab Anal, 1998,12(6): 351-355.
4Hong CY, Chia KS. Markers of diabetic rephropathy[J]. J Diabetes Complications, 1998,12(1): 43-60.
5Gejyo F, Suzuki S, Arakaua M, et al. Dialysis-related anyloidasis and clinical significance of extracorporeal removal of beta 2 microglibulin[J]. Ther Apher, 1997, 1 (12): 126-128.
6Aviles A, Diaz NR, Neri N, et al. Angiocontric nasal T/natural killer cell lymphoma:a single centre study of prognostic factors in 108 patients[J]. Clin Lab Haematol,2000,22(4) :215-220.
7Idasiak Piechocka J, Krzymanski M, et al. The role of tubulointerstitial changes in progression of kidney function failure in patients with chromic glomerulonephritis [J].Przegl lek,1996,53(5) :443-453.
8Monaco HL. The transthyretin retinol binding protein complex[J]. Biochim Biophys Acta, 2000, 1482 (1-2): 65-72.
9Matsuura K, Ikoma S, Watanabe M, et al. Some Bence Jones proteins enter cultured renal tubular cells, reach nuclei and induc cell death[J]. Immunology, 1999, 98(4):584-589.
10Guan S. Inhibition of Na-K-ATPase activity and gene expression by myeloma light chain in proximal tubule celles[J]. J Investig Med,1999,47(9) :496-501.
5Oniki K,Saruwatari J,Izuka T,et al. Influence of the PNPLA3 :738409 polymorphism on non-alcoholic faty liver disease and renal function among normal weight subjects. PLoS One, 2015,10(7 ):e0132640.
6Yokoyama A, Mizukami T, Matsui T, et al. Genetic polymorphisms of alcohol dehydrogenase- 1B and aldehyde dehydrngenase-2 and livm:irrhnsis, chronic calcific pancreatitis, diabetes mellitus, and hypertension among Japanese alcohnlic men. Alcohnl Clin Exp Res,2013,37(8):1391-1401.
7Matsumoto N, Arase Y,Kawamura Y,et al. Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of 11.126 mg/dL and HbAlc level of :< 6.4% in Japan. Intern Med,2015,54 (8):875-880.
8Solar E, Gin,s P. Challenges cirrhosis: Palhophysiology of renal Dis,2015,33(4):534-538.
9and management of liver dysfunction in cirrhosis.Dig Park SY,Jung SE,Jeong WK,et al. Renal function impairment in liver cirrhosis:preliminary results with diffusion-weighted imaging at 3 T. AJR ,2015,204(5):1024-1030.
10Puzzolante C,Vecchia M,Zona S,et al.Monitoring renal function during combination therapy with telaprevir in HIV/HCV co-infected patients with advanced/fibrosis cirrhosis.J Int AIDS Soe,2014,17(4 Suopl 3):19627.
